Morgan Stanley Investment Management -

Bayes and Base Rates 2.0: How History Can Guide Our Assessment of the Future

featured

Michael Mauboussin - Managing Director
Dan Callahan, CFA - Vice President


  • This is a follow up to our recent report, “Bayes and Base Rates,” which argued that to anticipate what is going to happen, it is useful to start with base rates as a prior probability distribution and to update your view based on new information.
  • That report sparked interest and some questions that we address, including how to handle inflation, the appropriate reference class, and groundbreaking technologies.
  • Comparing the projected sales growth rates of a couple of companies, including OpenAI, to base rates revealed that these forecasts are highly improbable in the context of history. 
  • Base rates are dynamic distributions, and nothing in past results says OpenAI's projected rates of growth are unachievable. 
  • Factors working in favor of OpenAI are rapid adoption of the product, high one-year sales growth, and the fact that intangible-intensive businesses have proven they can grow fast. 
  • On the other hand, there have been numerous disruptive innovations since 1950, and most of the all-time leaders in sales growth have done so through M&A rather than organically.

READ MORE FROM MORGAN STANLEY INVESTMENT MANAGEMENT

 

IMPORTANT INFORMATION

The views and opinions are those of the author as of the date of publication and are subject to change at any time due to market or economic conditions and may not necessarily come to pass. The views expressed do not reflect the opinions of all investment personnel at Morgan Stanley Investment Management (MSIM) and its subsidiaries and affiliates (collectively the Firm”), and may not be reflected in all the strategies and products that the Firm offers.

This material is for the benefit of persons whom the Firm reasonably believes it is permitted to communicate to and should not be forwarded to any other person without the consent of the Firm. It is not addressed to any other person and may not be used by them for any purpose whatsoever. It is the responsibility of every person reading this material to fully observe the laws of any relevant country, including obtaining any governmental or other consent which may be required or observing any other formality which needs to be observed in that country.

This material is a general communication, which is not impartial, is for informational and educational purposes only, not a recommendation to purchase or sell specific securities, or to adopt any particular investment strategy. Information does not address financial objectives, situation or specific needs of individual investors.

Any charts and graphs provided are for illustrative purposes only. Any performance quoted represents past performance. Past performance does not guarantee future results. All investments involve risks, including the possible loss of principal.

Prior to making any investment decision, investors should carefully review the strategy’s relevant offering document. For the complete content and important disclosures, refer to the article pdf.

Share this post

Sign Up Now for Full Access to Articles and Podcasts!

Unlock full access to our vast content library by registering as an institutional investor

Register

Contacts


Morgan Stanley

Morgan Stanley Investment Management’s Insurance Solutions team proudly supports our insurance clients with bespoke investment solutions and a comprehensive range of strategies that align well with insurers’ investment objectives and risk tolerances. We provide risk-based capital efficient solutions across public and private market strategies, and add value through thought leadership across insurance research, portfolio management, strategic asset allocation, reporting, risk management, and rating agency/regulatory considerations.

Joel Cramer, CFA
Managing Director, Head of North American Insurance Solutions
joel.cramer@morganstanley.com
Office: 312 706 4216
Mobile: 630 222 6765
 
1585 Broadway,
New York, NY 10036

 

View the contributor page

Sign Up Now for Full Access to Articles and Podcasts!

Unlock full access to our vast content library by registering as an institutional investor .

Create an account

Already have an account ? Sign in

Ѐ Ё Ђ Ѓ Є Ѕ І Ї Ј Љ Њ Ћ Ќ Ѝ Ў Џ А Б В Г Д Е Ж З И Й К Л М Н О П Р С ΄ ΅ Ά · Έ Ή Ί Ό Ύ Ώ ΐ Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Ё Ђ Ѓ Є Ѕ І Ї Ј Љ Њ Ћ Ќ Ў Џ А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Ā ā Ă ă Ą ą Ć ć Ĉ ĉ Ċ ċ Č č Ď ď Đ đ Ē ē Ĕ ĕ Ė fi fl œ æ ß